Easel Biotechnologies, LLC

Easel Biotechnologies, LLC, headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Bristol-Myers Squibb Company, which influences its climate commitments and initiatives.

As part of its corporate family relationship, Easel Biotechnologies inherits climate-related targets and performance metrics from Bristol-Myers Squibb Company. This includes commitments to the Science Based Targets initiative (SBTi) and participation in the Carbon Disclosure Project (CDP), both of which are cascaded down from the parent organisation. However, specific reduction targets or achievements for Easel Biotechnologies are not detailed.

The absence of direct emissions data suggests that Easel Biotechnologies is still in the process of establishing its own climate strategy, potentially aligning with the broader sustainability goals set by Bristol-Myers Squibb. As the company develops its initiatives, it may adopt industry-standard climate terminology and practices to enhance its environmental impact and transparency.